Pharmas have largely stayed out of the way as the Obama reform plan has moved through Congress, apparently considering the $80 billion deal they struck to be largely to their benefit. But now, at the final hour, liberal Democrats may undermine the status quo, with some pushing to make pharmas pay to close the "doughnut hole" in senior drug coverage. Article